LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
4.770
-0.020 (-0.42%)
At close: Aug 18, 2026, 4:00 PM EDT
4.850
+0.080 (1.68%)
After-hours: Aug 18, 2026, 7:36 PM EDT
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $149.88 million as of August 18, 2026. Its market cap has decreased by -86.12% in one year.
Market Cap
149.88M
Enterprise Value
-69.56M
1-Year Change
-86.12%
Ranking
Category
Stock Price
$4.77
ChartMarket Cap Chart
Since March 22, 2024, LENZ Therapeutics's market cap has decreased from $413.64M to $149.88M, a decrease of -63.77%. That is a compound annual growth rate of -34.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 149.88M | -70.06% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 155.76M |
| Kazia Therapeutics | 154.49M |
| Unicycive Therapeutics | 153.48M |
| Spruce Biosciences | 151.29M |
| Jyong Biotech | 149.95M |
| Milestone Pharmaceuticals | 149.66M |
| Equillium | 149.21M |
| Tiziana Life Sciences | 146.76M |